Edap Tms S A Adr (EDAP)

Oct 23, 2025

EDAP to Announce Third Quarter 2025 Financial Results on November 6, 2025 - GlobeNewswire Inc.

Oct 23, 2025

Oct 20, 2025

EDAP Secures €36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One® Robotic HIFU - Sahm

Oct 20, 2025

Oct 17, 2025

Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation - Placera.se

Oct 17, 2025

Oct 15, 2025

Cash per share of EDAP TMS SA Sponsored ADR – GETTEX:EDA - TradingView

Oct 15, 2025

Sep 29, 2025

Will EDAP TMS S.A. Depositary Receipt stock outperform value stocksMarket Sentiment Report & Fast Entry High Yield Stock Tips - newser.com

Sep 29, 2025

Sep 10, 2025

EDAP TMS Focuses on Robotic HIFU Leadership in Prostate Cancer - MSN

Sep 10, 2025

Sep 08, 2025

France approves reimbursement for EDAP’s prostate cancer treatment - Investing.com

Sep 08, 2025

Aug 31, 2025

Market reaction to NDLS’s recent news2025 Trade Ideas & Real-Time Stock Price Movement Reports - Newser

Aug 31, 2025

Aug 28, 2025

Earnings call transcript: EDAP TMS Q2 2025 reports revenue growth, stock rises - Investing.com

Aug 28, 2025

Aug 27, 2025

EDAP TMS Secures EUR 36 Million Credit Facility for Growth - The Globe and Mail

Aug 27, 2025

Aug 26, 2025

EDAP secures €36 million credit facility from European Investment Bank By Investing.com - Investing.com

Aug 26, 2025

Aug 19, 2025

How hedge fund analytics apply to BP P.L.C. ADRhedged stock2025 Trading Recap & Free Daily Entry Point Trade Alerts - Newser

Aug 19, 2025

Aug 16, 2025

Will Suburban Propane Partners L.P. Limited Partnership benefit from macro trendsDay Trade & Low Risk Investment Opportunities - Newser

Aug 16, 2025

Aug 08, 2025

Tools to monitor EDAP TMS S.A. Depositary Receipt recovery probabilityFree Risk Adjusted Technical Entry Plan - Newser

Aug 08, 2025

Jun 05, 2025

EDAP TMS at Jefferies Conference: Strategic Shift to HIFU Therapy - Investing.com

Jun 05, 2025

Jun 05, 2025

EDAP TMS at Jefferies Conference: Strategic Shift to HIFU Therapy By Investing.com - Investing.com India

Jun 05, 2025

Jun 02, 2025

edap tms sa announces shareholder meeting for june 2025 By Investing.com - Investing.com India

Jun 02, 2025

Jun 02, 2025

edap tms sa announces shareholder meeting for june 2025 - Investing.com

Jun 02, 2025

May 18, 2025

Improved Revenues Required Before EDAP TMS S.A. (NASDAQ:EDAP) Stock's 28% Jump Looks Justified - Sahm

May 18, 2025

May 16, 2025

H.C. Wainwright cuts EDAP stock price target to $14 By Investing.com - Investing.com South Africa

May 16, 2025

May 16, 2025

H.C. Wainwright cuts EDAP stock price target to $14 - Investing.com

May 16, 2025

Apr 29, 2025

Focal ablation shows promise in prostate cancer trial By Investing.com - Investing.com South Africa

Apr 29, 2025

Apr 04, 2025

Jefferies cuts EDAP TMS stock rating, slashes target to $2 - Investing.com

Apr 04, 2025

Mar 28, 2025

Piper Sandler cuts EDAP stock price target to $4.50, keeps rating - Investing.com

Mar 28, 2025

Mar 27, 2025

Earnings call transcript: EDAP TMS Q4 2024 sees revenue growth, stock surges - Investing.com

Mar 27, 2025

Sep 23, 2024

EDAP's Avenda Deal For AI-Assisted Cancer Care Likely To Drive Stock - Barchart.com

Sep 23, 2024

May 17, 2024

EDAP shares hold as analyst reiterates $19 target on growth - Investing.com

May 17, 2024

Mar 19, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 19, 2024

Aug 31, 2022

EDAP Forecast — Price Target — Prediction for 2026 - TradingView

Aug 31, 2022

Nov 13, 2019

The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher - Benzinga

Nov 13, 2019

Feb 05, 2019

Biotech & Pharma News, Stocks, FDA Decision, Clinical Trials - RTTNews

Feb 05, 2019

Feb 21, 2018

Technical Analysis of EDAP TMS SA Sponsored ADR (NASDAQ:EDAP) - TradingView

Feb 21, 2018

Jul 20, 2017

EDAP Stock Price and Chart — NASDAQ:EDAP - TradingView

Jul 20, 2017

Oct 10, 2013

Perkins Capital Raises Exposure in EDAP TMS - Insider Monkey

Oct 10, 2013

Oct 30, 2007

Edap Signs US$20 Mln Securities Purchase Accord To Fund US Clinical Studies Of Ablatherm-HIFU SystemQuick Facts - RTTNews

Oct 30, 2007